SIVIDON DIAGNOSTICS
Based in Cologne, Germany, Sividon Diagnostics is a management buyout from Siemens Healthcare Diagnostics in Cologne. The aim of Sividon team of experienced scientists and managers was and still is, the quality of companion diagnostics in oncology to improve their products sustainably. So in the future treatment decisions could in cancer - especially breast cancer - will be further improved by an individualized, evidence-based diagnosis. In this way Sividon is also supported by an established international network of renowned experts. In addition to the many years of professional experience in molecular diagnostics, there are the extensive rights and to the year 2004 reaching back arrangements that characterize the team and Sividon.
SIVIDON DIAGNOSTICS
Industry:
Health Care Health Diagnostics Medical Medical Device
Founded:
2010-01-01
Address:
Kölln-reisiek, Schleswig-Holstein, Germany
Country:
Germany
Website Url:
http://www.sividon.com
Total Employee:
11+
Status:
Closed
Contact:
49-(0)-221-669-561-00
Email Addresses:
[email protected]
Total Funding:
55.25 K USD
Technology used in webpage:
Google Google Cloud Parallels Plesk Panel Google Cloud Oregon
Similar Organizations
Quantitative Radiology Solutions
Quantitative Radiology Solutions offers advanced body-wide quantification of medical images.
xRapid
xRapid is a mobile health diagnosis through disruptive solutions leveraging the use of artificial intelligence.
Current Advisors List
Current Employees Featured
Founder
Investors List
EASME - EU Executive Agency for SMEs
EASME - EU Executive Agency for SMEs investment in Grant - Sividon Diagnostics
Creathor Ventures
Creathor Ventures investment in Private Equity Round - Sividon Diagnostics
Rheinland Venture Capital
Rheinland Venture Capital investment in Private Equity Round - Sividon Diagnostics
KfW
KfW investment in Private Equity Round - Sividon Diagnostics
Official Site Inspections
http://www.sividon.com
- Host name: 217-160-0-102.elastic-ssl.ui-r.com
- IP address: 217.160.0.102
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Sividon Diagnostics"
Sividon Diagnostics - Crunchbase Company Profile
Based in Cologne, Germany, Sividon Diagnostics is a management buyout from Siemens Healthcare Diagnostics in Cologne. The aim of Sividon team of …See details»
Sividon Diagnostics Company Profile 2024: Valuation, …
Sividon Diagnostics General Information Description. Developer of in-vitro diagnostics products. The company provides EndoPredict, a kit-based RNA …See details»
Sividon Diagnostics GmbH - Life-Sciences-Europe.com
Jul 1, 2010 Sividon Diagnostics is a leading breast cancer prognostic company. Sividon was spun out of Siemens Healthcare Diagnostics in 2010 as part of a management buyout. Their …See details»
Myriad Acquires Sividon Diagnostics - Myriad Genetics
5 days ago Myriad Acquires Sividon Diagnostics SALT LAKE CITY, May 31, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics , Inc. (NASDAQ:MYGN), a leader in molecular diagnostics …See details»
Sividon Diagnostics - Products, Competitors, Financials, Employees ...
Serving as Sividon’s CEO he oversaw the development of EndoPredict, a new standard to target breast cancer therapy and later successfully sold the company to Myriad Genetics. As a …See details»
Myriad buys predictive breast cancer Dx startup Sividon for up to …
Jun 1, 2016 Myriad Genetics has acquired Siemens spinout Sividon Diagnostics for €35 million ($39.1 million) up front with the potential for €15 million ($16.8 million) in performance-based …See details»
Myriad Acquires Sividon Diagnostics | Technology Networks
Jun 1, 2016 Myriad Genetics, Inc. has acquired Sividon Diagnostics for €35 million upfront with the potential for €15 million in additional performance-based milestones. The transaction …See details»
Über Sividon Diagnostics GmbH - XING
Die Sividon Diagnostics GmbH wurde im Juli 2010 als Management Buy-Out der Firma Siemens Healthcare Diagnostics Products am Standort Köln gegründet. Ziel des Sividon-Teams aus …See details»
Myriad Genetics Acquires Sividon Diagnostics | Clinical Lab Products
Jun 7, 2016 Myriad Genetics Inc, Salt Lake City, has acquired Sividon Diagnostics, Köln, Germany, for an upfront payment of €35 million (approximately $56 million), with the potential …See details»
Sividon Diagnostics | VentureRadar
Diagnostics for oncology ... Find out more about Sividon Diagnostics, Healthtech and Life Sciences.See details»
Myriad Acquires Sividon Diagnostics for Up to $56M
May 31, 2016 Sividon was spun out of Siemens Healthcare Diagnostics in 2010 as part of a management buyout. Myriad said it expects the Sividon acquisition to be neutral to both …See details»
Sividon Diagnostics - Contacts, Employees, Board Members
Organization. Sividon Diagnostics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. ... Sividon Diagnostics has 1 …See details»
Myriad Acquires Maker of EndoPredict Breast Cancer Prognostic …
Jun 1, 2016 Myriad Genetics announced Tuesday it had acquired Sividon Diagnostics, the maker of EndoPredict, a test that predicts progression of breast cancer and fits with the …See details»
Kerstin Bohmann - Co-Founder, Chief Operating Officer and Head …
Primary Organization . Sividon Diagnostics . Location Kölln-reisiek, Schleswig-Holstein, Germany; Regions European Union (EU), Europe, Middle East, and Africa (EMEA) ... Sividon …See details»
Myriad Genetics, Sividon Diagnostics enter into co-marketing …
Jan 21, 2014 US-based Myriad Genetics and Germany-based Sividon Diagnostics have announced an exclusive co-marketing agreement for the sales and marketing of Sividon's …See details»
Myriad Genetics Adds Breast Cancer Prognostic Dx to Portfolio …
Jun 1, 2016 Myriad expects Sividon to generate $8 million in revenues in fiscal year 2017 from sales outside of the United States, Myriad officials said on a conference call following …See details»
Myriad Genetics and Sividon Diagnostics Announce Exclusive
Jan 20, 2014 'We are committed to contributing to the health of people in Europe through a strong sales and marketing organization that provides enhanced access to life-saving products …See details»
Sividon Diagnostics Genetics & Genomics News | GenomeWeb
The analysis showed that one out of 227 node-negative breast cancer patients with the lowest EPclin scores by Sividon's EndoPredict test experienced recurrence over 10 years. Sividon …See details»
Myriad to Co-market Sividon Breast Cancer Test | GenomeWeb
Jan 20, 2014 NEW YORK (GenomeWeb News) – Myriad Genetics GmbH and Sividon Diagnostics today announced a deal granting Myriad the exclusive rights to co-market …See details»
From High-Throughput Microarray-Based Screening to Clinical
Aug 29, 2013 Several multigene tests have been developed for breast cancer patients to predict the individual risk of recurrence. Most of the first generation tests rely on proliferation …See details»